MENU
TRUH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

TRUH stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
TRUH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for TRUH with price predictions
Sep 24, 2026

TRUH's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for TRUH moved out of overbought territory on August 26, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 4 instances where the indicator moved out of the overbought zone. In 3 of the 4 cases the stock moved lower in the days that followed. This puts the odds of a move down at 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for TRUH turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 3 similar instances when the indicator turned negative. In 2 of the 3 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRUH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on TRUH as a result. In 6 of 6 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

Following a +1.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRUH advanced for three days, in 15 of 17 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

TRUH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing, under normal market circumstances, at least 80% of its total assets in equity securities of healthcare-related companies or instruments that provide exposure to healthcare-related companies as determined by the Adviser. For purposes of this policy, the term “assets” means net assets plus the amount of any borrowings for investment purposes. The fund is non-diversified.

Market Cap

The average market capitalization across the VanEck Healthcare TruSector ETF (TRUH) ETF is 170.33B. The market cap for tickers in the group ranges from 9.47B to 1.03T. LLY holds the highest valuation in this group at 1.03T. The lowest valued company is PODD at 9.47B.

High and low price notable news

The average weekly price growth across all stocks in the VanEck Healthcare TruSector ETF (TRUH) ETF was 1%. For the same ETF, the average monthly price growth was -3%, and the average quarterly price growth was 0%. MRNA experienced the highest price growth at 23%, while CNC experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the VanEck Healthcare TruSector ETF (TRUH) ETF was -6%. For the same stocks of the ETF, the average monthly volume growth was 4% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 32
P/E Growth Rating: 41
Price Growth Rating: 42
SMR Rating: 56
Profit Risk Rating: 67
Seasonality Score: -15 (-100 ... +100)
View a ticker or compare two or three
TRUH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
335 Madison Ave.19th FloorNew York
Phone
888-658-8287
Web
www.marketvectorsetfs.com
TRUH's RSI Indicator peaks and leaves overbought zone